PT3515924T - Formas cristalinas - Google Patents

Formas cristalinas

Info

Publication number
PT3515924T
PT3515924T PT177714367T PT17771436T PT3515924T PT 3515924 T PT3515924 T PT 3515924T PT 177714367 T PT177714367 T PT 177714367T PT 17771436 T PT17771436 T PT 17771436T PT 3515924 T PT3515924 T PT 3515924T
Authority
PT
Portugal
Prior art keywords
crystalline forms
crystalline
forms
Prior art date
Application number
PT177714367T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of PT3515924T publication Critical patent/PT3515924T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT177714367T 2016-09-22 2017-09-21 Formas cristalinas PT3515924T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2016072562 2016-09-22

Publications (1)

Publication Number Publication Date
PT3515924T true PT3515924T (pt) 2022-03-11

Family

ID=59923448

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177714367T PT3515924T (pt) 2016-09-22 2017-09-21 Formas cristalinas

Country Status (27)

Country Link
US (4) US10730896B2 (enExample)
EP (2) EP3515924B1 (enExample)
JP (1) JP7097369B2 (enExample)
KR (1) KR102552795B1 (enExample)
CN (1) CN109715639B (enExample)
AU (1) AU2017331930B2 (enExample)
CA (1) CA3037794A1 (enExample)
CL (1) CL2019000728A1 (enExample)
CY (1) CY1125052T1 (enExample)
DK (1) DK3515924T3 (enExample)
EA (1) EA201990723A1 (enExample)
ES (1) ES2908572T3 (enExample)
HR (1) HRP20220234T1 (enExample)
HU (1) HUE057772T2 (enExample)
IL (1) IL265445B2 (enExample)
LT (1) LT3515924T (enExample)
MA (1) MA46266B1 (enExample)
MX (1) MX381590B (enExample)
MY (1) MY193080A (enExample)
PH (1) PH12019500567B1 (enExample)
PL (1) PL3515924T3 (enExample)
PT (1) PT3515924T (enExample)
RS (1) RS62946B1 (enExample)
SI (1) SI3515924T1 (enExample)
TW (1) TWI752086B (enExample)
UA (1) UA124073C2 (enExample)
WO (1) WO2018055016A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE057772T2 (hu) 2016-09-22 2022-06-28 Idorsia Pharmaceuticals Ltd Kristályos formák
MA49887A (fr) 2017-03-15 2020-06-24 Idorsia Pharmaceuticals Ltd Administration sous-cutanée d'un antagoniste du récepteur p2y12
JP7490881B2 (ja) 2020-07-15 2024-05-27 イドルシア・ファーマシューティカルズ・リミテッド P2y12受容体アンタゴニストを有する水性医薬組成物
KR20240033005A (ko) 2021-07-13 2024-03-12 이도르시아 파마슈티컬스 리미티드 4-((r)-2-{[6-((s)-3-메톡시-피롤리딘-1-일)-2-페닐-피리미딘-4-카르보닐]-아미노}-3-포스포노-프로피오닐)-피페라진-1-카르복실산부틸 에스테르의 합성 방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373586A (en) 1976-12-09 1978-06-30 Mitsubishi Chem Ind Ltd New penicillin derivatives
CA2020437A1 (en) 1989-07-05 1991-01-06 Yoshihide Fuse Cinnamamide derivative
ATE303988T1 (de) 1999-06-14 2005-09-15 Lilly Co Eli Inhibitoren von serin proteasen
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
PL377053A1 (pl) 2002-12-11 2006-01-23 Schering Aktiengesellschaft Związki 2-aminokarbonylo-chinoliny jako antagonisty receptora płytkowego difosforanu adenozyny
JP4621659B2 (ja) 2003-04-09 2011-01-26 ワイス・エルエルシー [2−(8,9−ジオキソ−2,6−ジアザビシクロ[5.2.0]ノナ−1(7)−エン−2−イル)アルキル]ホスホン酸の誘導体およびn−メチル−d−アスパルテート(nmda)受容体アンタゴニストとしてのその使用
TW200640877A (en) 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
NZ568335A (en) 2005-10-21 2011-07-29 Actelion Pharmaceuticals Ltd Piperazine derivatives as antimalarial agents
CL2007002920A1 (es) 2006-10-13 2008-06-06 Actelion Pharmaceuticals Ltd Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
AR063518A1 (es) 2006-10-25 2009-01-28 Actelion Pharmaceuticals Ltd Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis
JP4785881B2 (ja) 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
EP2148871A1 (en) 2007-04-23 2010-02-03 Sanofi-Aventis Quinoline-carboxamide derivatives as p2y12 antagonists
MY153749A (en) 2007-11-29 2015-03-13 Actelion Pharmaceuticals Ltd Phosphonic acid derivates and their use as p2y12 receptor antagonists
EP2238127B1 (en) 2007-12-26 2012-08-15 Sanofi Pyrazole-carboxamide derivatives as p2y12 antagonists
JP5504171B2 (ja) 2007-12-26 2014-05-28 サノフイ P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
CN102369197B (zh) 2009-04-08 2013-11-06 埃科特莱茵药品有限公司 作为adp受体拮抗剂的6-(3-氮杂-二环[3.1.0]己-3-基)-2-苯基-嘧啶
CA2756654C (en) 2009-04-22 2017-08-22 Actelion Pharmaceuticals Ltd Thiazole derivatives and their use as p2y12 receptor antagonists
HUE057772T2 (hu) 2016-09-22 2022-06-28 Idorsia Pharmaceuticals Ltd Kristályos formák
MA49887A (fr) 2017-03-15 2020-06-24 Idorsia Pharmaceuticals Ltd Administration sous-cutanée d'un antagoniste du récepteur p2y12
JP7490881B2 (ja) 2020-07-15 2024-05-27 イドルシア・ファーマシューティカルズ・リミテッド P2y12受容体アンタゴニストを有する水性医薬組成物

Also Published As

Publication number Publication date
LT3515924T (lt) 2022-03-10
JP2019529553A (ja) 2019-10-17
KR20190052704A (ko) 2019-05-16
US20200017534A1 (en) 2020-01-16
HUE057772T2 (hu) 2022-06-28
PH12019500567A1 (en) 2019-11-18
US20210009614A1 (en) 2021-01-14
IL265445A (en) 2019-05-30
ES2908572T3 (es) 2022-05-03
US11365209B2 (en) 2022-06-21
EP3981774A1 (en) 2022-04-13
IL265445B2 (en) 2024-05-01
MA46266A (fr) 2019-07-31
SI3515924T1 (sl) 2022-04-29
CY1125052T1 (el) 2024-02-16
AU2017331930B2 (en) 2021-07-15
CN109715639B (zh) 2022-04-19
MY193080A (en) 2022-09-26
CA3037794A1 (en) 2018-03-29
US12227532B2 (en) 2025-02-18
MX381590B (es) 2025-03-12
RS62946B1 (sr) 2022-03-31
US20250163086A1 (en) 2025-05-22
CN109715639A (zh) 2019-05-03
IL265445B1 (en) 2024-01-01
WO2018055016A1 (en) 2018-03-29
AU2017331930A1 (en) 2019-03-07
CL2019000728A1 (es) 2019-07-05
UA124073C2 (uk) 2021-07-14
EP3515924B1 (en) 2021-12-15
KR102552795B1 (ko) 2023-07-06
EP3515924A1 (en) 2019-07-31
NZ750772A (en) 2023-10-27
US20220275011A1 (en) 2022-09-01
TW201813965A (zh) 2018-04-16
EA201990723A1 (ru) 2019-10-31
HRP20220234T1 (hr) 2022-05-13
BR112019004845A2 (pt) 2019-06-04
PL3515924T3 (pl) 2022-04-11
MA46266B1 (fr) 2022-02-28
US10730896B2 (en) 2020-08-04
PH12019500567B1 (en) 2024-01-31
JP7097369B2 (ja) 2022-07-07
MX2019003093A (es) 2019-07-18
TWI752086B (zh) 2022-01-11
DK3515924T3 (da) 2022-03-21

Similar Documents

Publication Publication Date Title
IL273730A (en) crystalline forms
AU201616678S (en) Cylindres
DK3270751T3 (en) Foodprocessor
AU201710580S (en) Bookrack
SG10201911417PA (en) Crystalline compounds
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
IL262674A (en) crystals
GB201614939D0 (en) Crystalline hydrate
SG10202101979TA (en) Crystalline forms of c21h22ci2n4o2
GB201419174D0 (en) Crystalline forms
SI3529236T1 (sl) Kristalinične oblike eravaciklina
IL265445A (en) crystalline forms
IL253479A0 (en) Crystalline forms of efinconazole
LT3390358T (lt) Kristalinis eravaciklino bis-hidrochloridas
PL3350179T3 (pl) Krystaliczne postacie
ZA201902553B (en) Crystalline forms
IL261795A (en) Crystalline form
GB201715010D0 (en) Crystalline forms
GB201708856D0 (en) Seletalisib crystalline forms
HK40009744A (en) Crystalline forms
GB201604759D0 (en) Crystalline compounds
GB201704789D0 (en) Crystalline compounds
AU5499P (en) T15-1218 Bituminaria bituminosa
AU201713060S (en) SUNSHADE - triangle
AU2016376V (en) NinbellaPurple Alyogyne huegelii